InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Solid Biosciences Inc.

SLDB Clue Score20
United States Fiscal year ends December CIK 0001707502 Results filed 6 Mar 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
Clare Kahn
11 Mar 2025
Director
Buy
1,860
$5.34
$9.92K
Perceptive Advisors LLC
19 Feb 2025
Director
Buy indirect
5,000,000
$4.03
$20.15M
Bain Capital Life Sciences Investors, LLC
19 Feb 2025
10% owner
Buy indirect
1,000,000
$4.03
$4.03M
Adage Capital Management, L.P.
18 Feb 2025
10% owner
Buy indirect
252,545
$7.56
$1.91M
Clare Kahn
7 Jun 2024
Director
Buy
1,100
$7.67
$8.44K
Ra Capital Management, L.p.
11 Jan 2024
Director
Buy indirect
904,160
$5.53
$5.00M
Perceptive Advisors LLC
11 Jan 2024
Director
Buy indirect
3,410,713
$5.53
$18.86M
Perceptive Advisors LLC
23 Mar 2021
Director
Buy indirect
2,608,695
$5.75
$15.00M
Ra Capital Management, L.p.
19 Mar 2021
Director
Buy indirect
2,206,685
$5.75
$12.69M
Perceptive Advisors LLC
25 Jul 2019
Director
Buy indirect
2,822,581
$4.65
$13.13M
Perceptive Advisors LLC
30 Jan 2018
Director
Buy indirect
20,000
$27.33
$546.52K
Perceptive Advisors LLC
30 Jan 2018
Director
Buy indirect
1,000,000
$16.00
$16.00M
Rajeev M. Shah
30 Jan 2018
Director
Buy indirect
1,000,000
$16.00
$16.00M
Adam Koppel
30 Jan 2018
Director
Buy indirect
300,000
$16.00
$4.80M
Show all 115 transactions →

What was left out

Form 4 filings counted 337
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 29
Sales on a Rule 10b5-1 plan 35
Sales straight out of an exercise 7
Sales at will 59
Transactions with no price 0
Shares from compensation/vesting 31,237,837
Sales filed before the plan box existed 43
History held since 30 Jan 2018